Paradigm Biopharmaceuticals Limited

ASX (AUD): Paradigm Biopharmaceuticals Limited (PAR)

Last Price

0.345

Today's Change

-0.01 (2.81%)

Day's Change

0.337 - 0.36

Trading Volume

719,247

Overview

Market Cap

137 Million

Shares Outstanding

397 Million

Avg Volume

866,752

Avg Price (50 Days)

0.36

Avg Price (200 Days)

0.38

PE Ratio

-6.90

EPS

-0.05

Earnings Announcement

29-Aug-2025

Previous Close

0.35

Open

0.36

Day's Range

0.337 - 0.36

Year Range

0.165 - 0.66

Trading Volume

719,247

Price Change Highlight

1 Day Change

-2.82%

5 Day Change

-16.87%

1 Month Change

-10.39%

3 Month Change

11.29%

6 Month Change

-41.03%

Ytd Change

-13.75%

1 Year Change

38.00%

3 Year Change

-74.25%

5 Year Change

-87.89%

10 Year Change

-1.10%

Max Change

-1.10%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment